July 10, 2025 · Form 4 insider transaction
MAHON PAUL A sold 7,738 shares of United Therapeutics Corporation at $300.48 per share, a transaction worth $2.33M. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 4 days after the transaction.
This is an exercise of stock options and sale of the resulting shares pursuant to a pre-arranged 10b5-1 plan entered into by the reporting person on December 24, 2024.; This transaction was executed in multiple trades at prices ranging from $300.03 to $300.99. The price reported above reflects the weighted average price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.